美国糖尿病学会2020年《孕期糖尿病诊治指南》摘译和解读

参考文献

[1] American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020[J]. Diabetes Care, 2020，43(Suppl 1): S14-S31. DOI: 10.2337/dc20-S002.

[2] American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2020[J]. Diabetes Care, 2020，43(Suppl 1): S183-S192. DOI: 10.2337/dc20-S014.

[3] Poltavskiy E, Kim DJ, Bang H. Comparison of screening scores for diabetes and prediabetes[J]. Diabetes Res Clin Pract, 2016，118: 146-153. DOI: 10.1016/j.diabres.2016.06.022.

[4] Feig DS, Hwee J, Shah BR, et al. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010[J]. Diabetes Care, 2014，37(6): 1590-1596. DOI: 10.2337/dc13-2717.

[5] Peng TY, Ehrlich SF, Crites Y, et al. Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014[J]. Am J Obstet Gynecol, 2017，216(2):

177.e1-177.e8. DOI: 10.1016/j.ajog.2016.10.007.

[6] Jovanovi? L, Liang Y, Weng W, et al. Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy[J]. Diabetes Metab Res Rev, 2015，31(7): 707-716. DOI: 10.1002/dmrr.2656.

[7] O′sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy[J]. Diabetes, 1964，13: 278-285.

[8] Brown FM, Wyckoff J. Application of one-step IADPSG versus two-step diagnostic criteria for gestational diabetes in the real world: impact on health services, clinical care, and outcomes[J]. Curr Diab Rep, 2017，17(10): 85. DOI: 10.1007/s11892-017-0922-z.

[9] Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships[J]. Diabetes, 2000，49(12): 2208-2211. DOI: 10.2337/diabetes.49.12.2208.

[10] Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial[J]. Diabetes Care, 2011，34(8): 1683-1688. DOI: 10.2337/dc11-0244.

[11] Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes[J]. N Engl J Med, 2009，361(14): 1339-1348. DOI: 10.1056/NEJMoa0902430.

[12] Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes[J]. N Engl J Med, 2005，352(24): 2477-2486. DOI: 10.1056/NEJMoa042973.

[13] McIntyre HD, Sacks DA, Barbour LA, et al. Issues with the diagnosis and classification of hyperglycemia in early pregnancy[J]. Diabetes Care, 2016，39(1): 53-54. DOI: 10.2337/dc15-1887.

[14] Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes[J]. Am J Obstet Gynecol, 1982，144(7): 768-773. DOI: 10.1016/0002-9378(82)90349-0.

[15] Horvath K, Koch K, Jeitler K, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis[J]. BMJ, 2010，340: c1395. DOI: 10.1136/bmj.c1395.

[16] Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes[J]. Diabetes Care, 2007，30(7): 1920-1925. DOI: 10.2337/dc07-0278.

[17] Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes[J]. Diabetes Care, 2009，32(6): 1046-1048. DOI: 10.2337/dc08-2061.

[18] Nielsen GL, M?ller M, S?rensen HT. HbA1C in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes[J]. Diabetes Care, 2006，29(12): 2612-2616. DOI: 10.2337/dc06-0914.

[19] Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus[J]. Diabetologia, 2000，43(1): 79-82. DOI: 10.1007/s001250050010.

[20] ACOG Committee Opinion No. 762: Prepregnancy Counseling[J]. Obstet Gynecol, 2019，133(1): e78-e89. DOI: 10.1097/AOG.0000000000003013.

[21] Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J]. Thyroid, 2017，27(3): 315-389. DOI: 10.1089/thy.2016.0457.

[22] Ramos DE. Preconception health: changing the paradigm on well-woman health[J]. Obstet Gynecol Clin North Am, 2019，46(3): 399-408. DOI: 10.1016/j.ogc.2019.04.001.

[23] Owens LA, Avalos G, Kirwan B, et al. ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes[J]. Diabetes Care, 2012，35(8): 1669-1671. DOI: 10.2337/dc12-0120.

[24] Bullo M, Tschumi S, Bucher BS, et al. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review[J]. Hypertension, 2012，60(2): 444-450. DOI: 10.1161/HYPERTENSIONAHA.112.196352.

[25] Taguchi N, Rubin ET, Hosokawa A, et al. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes[J]. Reprod Toxicol, 2008，26(2): 175-177. DOI: 10.1016/j.reprotox.2008.06.009.

[26] Bateman BT, Hernandez-Diaz S, Fischer MA, et al. Statins and congenital malformations: cohort study[J]. BMJ, 2015，350: h1035. DOI: 10.1136/bmj.h1035.

[27] Taylor C, McCance DR, Chappell L, et al. Implementation of guidelines for multidisciplinary team management of pregnancy in women with pre-existing diabetes or cardiac conditions: results from a UK national survey[J]. BMC Pregnancy Childbirth, 2017，17(1): 434. DOI: 10.1186/s12884-017-1609-9.

[28] Maresh MJ, Holmes VA, Patterson CC, et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes[J]. Diabetes Care, 2015，38(1): 34-42. DOI: 10.2337/dc14-1755.

[29] Cyganek K, Skupien J, Katra B, et al. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control[J]. Endocrine, 2017，55(2): 447-455. DOI: 10.1007/s12020-016-1134-z.

[30] Abell SK, Boyle JA, de Courten B, et al. Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes[J]. Aust N Z J Obstet Gynaecol, 2017，57(3): 308-314. DOI: 10.1111/ajo.12521.

[31] Cyganek K, Skupien J, Katra B, et al. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control[J]. Endocrine, 2017，55(2): 447-455. DOI: 10.1007/s12020-016-1134-z.

[32] Kristensen K, ?gge LE, Sengpiel V, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes(CONCEPTT): an observational cohort study of 186 pregnancies[J]. Diabetologia, 2019，62(7): 1143-1153. DOI: 10.1007/s00125-019-4850-0.

[33] Law GR, Gilthorpe MS, Secher AL, et al. Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes[J]. Diabetologia, 2017，60(4): 618-624. DOI: 10.1007/s00125-017-4205-7.

[34] Malek R, Davis SN. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus[J]. Expert Opin Drug Metab Toxicol, 2016，12(6): 691-699. DOI: 10.1080/17425255.2016.1187131.

[35] Balsells M, García-Patterson A, Solà I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis[J]. BMJ, 2015，350: h102. DOI: 10.1136/bmj.h102.

[36] Sénat MV, Affres H, Letourneau A, et al. Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial[J]. JAMA, 2018，319(17): 1773-1780. DOI: 10.1001/jama.2018.4072.

[37] LGE H, Stridsklev S, Júlíusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs[J]. J Clin Endocrinol Metab, 2018，103(4): 1612-1621. DOI: 10.1210/jc.2017-02419.

[38] Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis[J]. PLoS Med, 2019，16(8): e1002848. DOI: 10.1371/journal.pmed.1002848.

[39] Hanem LGE, Salvesen ?, Juliusson PB, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors(PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial[J]. Lancet Child Adolesc Health, 2019，3(3): 166-174. DOI: 10.1016/S2352-4642(18)30385-7.

[40] Barbour LA, Scifres C, Valent AM, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes[J]. Am J Obstet Gynecol, 2018，219(4):

367.e1-367.e7. DOI: 10.1016/j.ajog.2018.06.013.

[41] Barbour LA, Feig DS. Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach[J]. Diabetes Care, 2019，42(3): 396-399. DOI: 10.2337/dci18-0055.

[42] Voutetakis A, Pervanidou P, Kanaka-Gantenbein C. Aspirin for the prevention of preeclampsia and potential consequences for fetal brain development[J]. JAMA Pediatr, 2019，173(7): 619-620. DOI: 10.1001/jamapediatrics.2019.1260.

[43] Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice[J]. Hypertension, 2018，72(1): 24-43. DOI: 10.1161/HYPERTENSIONAHA.117.10803.

[44] American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy[J]. Obstet Gynecol, 2019，133(1): e26-e50. DOI: 10.1097/AOG.0000000000003020.

相关知识

解读《国际糖尿病联盟餐后血糖管理指南》
中国糖尿病足诊治指南，最新发布
《中国老年糖尿病诊疗指南（2021年版）》权威解读，依健康状态分级管理，提倡“简约治疗”
最新！时隔 4 年，《中国糖尿病防治指南 2024》发布，关注这 5 点
【妊娠期糖尿病症状】妊娠期糖尿病症状
我国首次发布《中国糖尿病膳食指南（2017）》
糖尿病饮食指南
糖尿病
「糖尿病」糖尿病的症状
妊娠期糖尿病的药物治疗原则 (原创)

网址: 美国糖尿病学会2020年《孕期糖尿病诊治指南》摘译和解读 https://www.trfsz.com/newsview81067.html